News

Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...
Living with Alzheimer’s disease can be both challenging and frightening. However, stories of resilience and hope can inspire ...
A pen, paper, and 30 seconds might be all it takes to uncover if you are struggling with early dementia signs, as Fiona ...
Some forgetfulness is part of the aging process. Recognizing when it could be something more can help families cope with a ...
A Finnish population study shows that signs related to Alzheimer's disease may already be found in the brain in middle age.
The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA ...
In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.
Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...
Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...
Neurons that die early in Alzheimer’s help drive brain waste removal. Treating this process sooner could change outcomes.
People in early stages of the disease may show other signs of cognitive deterioration such as being unable to follow directions or recipes, making serious financial errors, or struggling to maintain a ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...